lifestyle.clientim.com

Author: Moderna, Inc.

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Vaccine Candidate

December 18, 2025
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 17, 2025
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)

December 15, 2025